This will be brief.
On the issue of jurisdiction, we look at the policy measures at both levels of government and determine which ones we think are preferable. As Mr. Duceppe said, the proposal in the Hoskins report, which is a few years old and was commissioned by the current government, strikes us as interesting in several respects.
Admittedly, a public pharmacare program might cost governments a little more. However, as we pointed out in our brief, such a plan would allow Canada and the provinces to save on overall private and public health spending. This would control the growth in total spending. It would also have a positive effect on the cost of inflation for Canadians.